140 related articles for article (PubMed ID: 31257538)
1. Overexpression of microRNA‑21 inhibits the growth and metastasis of melanoma cells by targeting MKK3.
Zhou M; Yu X; Jing Z; Wu W; Lu C
Mol Med Rep; 2019 Aug; 20(2):1797-1807. PubMed ID: 31257538
[TBL] [Abstract][Full Text] [Related]
2. Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma.
Cui L; Li Y; Lv X; Li J; Wang X; Lei Z; Li X
Cell Physiol Biochem; 2016; 40(1-2):230-244. PubMed ID: 27855389
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑21 increases cell viability and suppresses cellular apoptosis in non‑small cell lung cancer by regulating the PI3K/Akt signaling pathway.
Wang T; Cai Z; Hong G; Zheng G; Huang Y; Zhang S; Dai J
Mol Med Rep; 2017 Nov; 16(5):6506-6511. PubMed ID: 28901419
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of miR‑21 promotes cell apoptosis in oral squamous cell carcinoma by upregulating PTEN.
Zheng Y; Xie J; Jiang F; Li Y; Chang G; Ma H
Oncol Rep; 2018 Nov; 40(5):2798-2805. PubMed ID: 30132571
[TBL] [Abstract][Full Text] [Related]
5. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway.
Hou Z; Quan J
Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑21 expression is associated with the clinical features of patients with gastric carcinoma and affects the proliferation, invasion and migration of gastric cancer cells by regulating Noxa.
Sun H; Wang P; Zhang Q; He X; Zai G; Wang X; Ma M; Sun X
Mol Med Rep; 2016 Mar; 13(3):2701-7. PubMed ID: 26847916
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
Wu Q; Han T; Sheng X; Zhang N; Wang P
Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
[TBL] [Abstract][Full Text] [Related]
10. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits HaCaT cell viability via the miR-21/PTEN/Akt signaling pathway.
Deng Y; Ma W
Mol Med Rep; 2018 Mar; 17(3):4062-4066. PubMed ID: 29286158
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑142‑5p modulates breast cancer cell proliferation and apoptosis by targeting phosphatase and tensin homolog.
Xu W; Wang W
Mol Med Rep; 2018 Jun; 17(6):7529-7536. PubMed ID: 29620260
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
14. MiR-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis.
Xu L; Leng H; Shi X; Ji J; Fu J; Leng H
Biomed Pharmacother; 2017 Jun; 90():524-530. PubMed ID: 28402921
[TBL] [Abstract][Full Text] [Related]
15. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer.
Xu G; Meng L; Yuan D; Li K; Zhang Y; Dang C; Zhu K
Oncol Rep; 2018 Jul; 40(1):39-48. PubMed ID: 29749532
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑21 regulates the biological behavior of esophageal squamous cell carcinoma by targeting RASA1.
Chen X; Cai S; Li B; Zhang X; Li W; Liang H; Cao X; Wang L; Wu Z
Oncol Rep; 2019 Mar; 41(3):1627-1637. PubMed ID: 30569149
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells.
Mao B; Xiao H; Zhang Z; Wang D; Wang G
Mol Med Rep; 2015 Oct; 12(4):4917-24. PubMed ID: 26151427
[TBL] [Abstract][Full Text] [Related]
18. miR‑21 inhibitor facilitates the anticancer activity of doxorubicin loaded nanometer in melanoma.
Wei X; You X; Zhang J; Zhou C
Oncol Rep; 2019 Jul; 42(1):414-424. PubMed ID: 31115580
[TBL] [Abstract][Full Text] [Related]
19. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
Lei L; Huang Y; Gong W
Oncol Rep; 2013 Dec; 30(6):2897-902. PubMed ID: 24084898
[TBL] [Abstract][Full Text] [Related]
20. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
Du G; Cao D; Meng L
Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
